+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Research Report on China's Gefitinib Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Gefitinib Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Investigation Report on China's Levofloxacin Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Levofloxacin Market 2021-2025

  • Report
  • June 2021
  • China
From
Investigation Report on China's Acetylcysteine Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Acetylcysteine Market 2021-2025

  • Report
  • June 2021
  • China
From
Investigation Report on China's Omalizumab Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Omalizumab Market 2021-2025

  • Report
  • June 2021
  • 50 Pages
  • China
From
Investigation Report on China's Tiotropium Bromide Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Tiotropium Bromide Market 2021-2025

  • Report
  • May 2021
  • 50 Pages
  • China
From
Investigation Report on China's Ambroxol Market, 2021-2025 - Product Thumbnail Image

Investigation Report on China's Ambroxol Market, 2021-2025

  • Report
  • April 2021
  • China
From
Investigation Report on China's Loratadine Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Loratadine Market, 2018-2022

  • Report
  • December 2018
  • 30 Pages
  • China
From
Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis, 2024-2032 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis, 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Fair-Market Value Compensation Rates for Pulmonary/Respiratory Diseases KOLs - United States - Product Thumbnail Image

Fair-Market Value Compensation Rates for Pulmonary/Respiratory Diseases KOLs - United States

  • Report
  • August 2023
  • 8 Pages
  • United States
From
Caffeine Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031 - Product Thumbnail Image

Caffeine Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

  • Report
  • February 2020
  • 120 Pages
  • Global
From
Phosphodiesterase (PDE) Inhibitors Market 2024-2028 - Product Thumbnail Image

Phosphodiesterase (PDE) Inhibitors Market 2024-2028

  • Report
  • December 2023
  • 165 Pages
  • Global
From
Epinephrine Autoinjector Market 2024-2028 - Product Thumbnail Image

Epinephrine Autoinjector Market 2024-2028

  • Report
  • November 2023
  • 154 Pages
  • Global
From
Montelukast API Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Montelukast API Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • July 2024
  • Global
From
Breathing Disorder & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Breathing Disorder & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • July 2024
  • Global
From
Asthma and COPD Drugs Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Asthma and COPD Drugs Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Bronchodilator Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Bronchodilator Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Chlorpheniramine Maleate Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Chlorpheniramine Maleate Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Respiratory Disease Vaccine Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Respiratory Disease Vaccine Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • July 2023
  • 110 Pages
  • Global
From
Asthma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Asthma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Cystic Fibrosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Cystic Fibrosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • July 2022
  • 112 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more